Clover Biopharmaceuticals, Ltd.
HKEX:2197.HK
1.57 (HKD) • At close September 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -808.305 | -95.123 | -789.163 | 650.624 | -1,315.818 | -1,136.085 | -4,701.553 | -1,314.75 | -456.449 | -456.449 | -24.292 | -24.292 |
| Depreciation & Amortization
| 0 | 21.287 | 56.42 | 28.229 | 28.502 | 28.168 | 17.295 | 7.194 | 2.892 | 2.892 | 1.199 | 1.199 |
| Deferred Income Tax
| 0 | 0 | 0 | -451.435 | -3,340.435 | 699.767 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 8.414 | 7.864 | 29.671 | 23.844 | 31.156 | 63.867 | 90.945 | 34.269 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | -42.406 | 76.685 | -36.474 | -439.556 | -468.903 | -1,930.52 | -21.816 | 375.754 | 375.754 | 9.283 | 9.283 |
| Accounts Receivables
| 0 | 24.102 | -23.525 | -0.581 | 2,877.147 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | -1.68 | 7.505 | -16.202 | -1,326.762 | -763.634 | -635.035 | -136.719 | -25.244 | -25.244 | -0.197 | -0.197 |
| Change In Accounts Payables
| 0 | 0 | 0 | -260.877 | -320.631 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | -64.828 | 92.705 | -19.691 | 887.206 | 294.731 | -1,295.485 | 114.903 | 400.998 | 400.998 | 9.48 | 9.48 |
| Other Non Cash Items
| 799.891 | -49.548 | 328.902 | -1,096.616 | 563.639 | 954.221 | 6,061.61 | 839.577 | 316.267 | 316.267 | 0.502 | 0.502 |
| Operating Cash Flow
| 0 | -157.926 | -297.485 | -430.393 | -1,132.077 | -558.732 | -462.223 | -455.526 | 238.464 | 238.464 | -13.309 | -13.309 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | -1.225 | -3.205 | -3.747 | -24.11 | -52.923 | -24.14 | -35.112 | -56.896 | -56.896 | -3.408 | -3.408 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 4.939 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -31.259 | 0 | 0 | 0 | -140.164 | -140.164 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | -12.428 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -7.786 | 1.86 | -1.069 | -23.26 | 62.787 | 157.781 | 13.595 | -140.253 | -140.253 | 2.109 | 2.109 |
| Investing Cash Flow
| 0 | -9.011 | -1.345 | -4.816 | -47.37 | 9.864 | 133.641 | -21.517 | -197.06 | -197.06 | -1.299 | -1.299 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | -23.48 | 0 | -3.988 | -2.236 | -2.236 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0.032 | 1,005.797 | 0 | 0 | 0 | -0.164 | -0.164 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -111.887 | -221.686 | 79.278 | 497.447 | 9.176 | 1,584.832 | 1,476.329 | 160.66 | 160.66 | 71.025 | 71.025 |
| Financing Cash Flow
| 0 | -111.887 | -221.686 | 79.278 | 497.447 | -14.304 | 1,584.832 | 1,472.341 | 158.424 | 158.424 | 71.025 | 71.025 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 1.734 | -8.075 | 12.977 | 33.767 | 51.443 | 6.908 | -7.269 | -16.082 | -16.082 | 0.058 | 0.058 |
| Net Change In Cash
| -458.774 | -138.545 | -264.295 | -441.347 | -579.516 | -255.865 | 631.579 | 494.015 | 367.49 | 367.49 | 112.95 | 112.95 |
| Cash At End Of Period
| 0 | -138.545 | -264.295 | 1,639.729 | 2,081.077 | 2,255.642 | 631.579 | 1,504.213 | 516.184 | 516.184 | 148.694 | 148.694 |